ARCHIVES

Therapeutic Modalities Improve Patient Quality of Life In Trials

This article is from The Cancer Letter archive.

Vol. 27 No. 2 | February 27, 2004

Download PDF Visit The Full Archive

Related Articles

Proteomics Promises Ways To Track Response To Therapy

April 25, 2003

FDA Grants Orphan Designation To E7777 in T-Cell Lymphoma

August 30, 2013

BSA, BSC Approve Concept for NCI Scholars Program

March 7, 1997

In Brief: Online Genetics Glossary; ORI Misconduct Finding

February 5, 1999

Step By Step: New Tenure Track, Appointments Process

August 5, 1994

New Screening Tool Helps GP ID Hereditary BC Risk

October 27, 2006